Nu Skin Enterprises (NYSE:NUS) Rating Lowered to C at TheStreet

Nu Skin Enterprises (NYSE:NUSGet Rating) was downgraded by equities research analysts at TheStreet from a “b” rating to a “c” rating in a report issued on Thursday, TheStreetRatingsTable reports.

Separately, StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Wednesday, June 22nd. Two research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $61.50.

Nu Skin Enterprises Trading Down 2.8 %

Shares of NUS stock opened at $43.35 on Thursday. Nu Skin Enterprises has a 1 year low of $39.40 and a 1 year high of $56.76. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.72 and a quick ratio of 0.95. The stock’s 50 day simple moving average is $44.22 and its two-hundred day simple moving average is $46.51. The company has a market cap of $2.18 billion, a PE ratio of 19.53 and a beta of 1.16.

Nu Skin Enterprises (NYSE:NUSGet Rating) last issued its quarterly earnings results on Wednesday, May 4th. The company reported $0.76 earnings per share for the quarter, topping the consensus estimate of $0.73 by $0.03. Nu Skin Enterprises had a return on equity of 19.85% and a net margin of 4.57%. The firm had revenue of $604.90 million for the quarter, compared to the consensus estimate of $579.70 million. During the same period in the prior year, the business posted $0.91 earnings per share. The company’s revenue for the quarter was down 10.7% on a year-over-year basis. Research analysts predict that Nu Skin Enterprises will post 3.62 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Ryan S. Napierski sold 25,000 shares of the stock in a transaction that occurred on Wednesday, May 25th. The stock was sold at an average price of $44.91, for a total value of $1,122,750.00. Following the transaction, the chief executive officer now owns 122,683 shares of the company’s stock, valued at $5,509,693.53. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, Chairman Steven Lund sold 21,200 shares of the stock in a transaction that occurred on Monday, May 16th. The stock was sold at an average price of $45.25, for a total value of $959,300.00. Following the transaction, the chairman now owns 180,374 shares of the company’s stock, valued at $8,161,923.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Ryan S. Napierski sold 25,000 shares of the stock in a transaction that occurred on Wednesday, May 25th. The stock was sold at an average price of $44.91, for a total value of $1,122,750.00. Following the completion of the transaction, the chief executive officer now directly owns 122,683 shares in the company, valued at approximately $5,509,693.53. The disclosure for this sale can be found here. Insiders have sold a total of 148,143 shares of company stock valued at $6,647,717 over the last quarter. 2.80% of the stock is owned by corporate insiders.

Institutional Trading of Nu Skin Enterprises

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Artemis Wealth Advisors LLC bought a new stake in Nu Skin Enterprises during the 2nd quarter valued at $33,000. Covestor Ltd bought a new stake in Nu Skin Enterprises during the 4th quarter valued at $48,000. Quadrant Capital Group LLC boosted its position in Nu Skin Enterprises by 47.1% during the 4th quarter. Quadrant Capital Group LLC now owns 1,068 shares of the company’s stock valued at $54,000 after acquiring an additional 342 shares in the last quarter. Gladius Capital Management LP bought a new stake in Nu Skin Enterprises during the 4th quarter valued at $98,000. Finally, Fifth Lane Capital LP bought a new stake in Nu Skin Enterprises during the 4th quarter valued at $162,000. Institutional investors own 93.79% of the company’s stock.

Nu Skin Enterprises Company Profile

(Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

See Also

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.